122 related articles for article (PubMed ID: 6610534)
1. Hypotensive reaction after infusion of a perfluorochemical emulsion.
Waxman K; Cheung CK; Mason GR
Crit Care Med; 1984 Jul; 12(7):609-10. PubMed ID: 6610534
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary complications after Fluosol administration to patients with life-threatening blood loss.
Police AM; Waxman K; Tominaga G
Crit Care Med; 1985 Feb; 13(2):96-8. PubMed ID: 3967511
[TBL] [Abstract][Full Text] [Related]
3. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
Tremper KK; Anderson ST
Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
[TBL] [Abstract][Full Text] [Related]
4. Effect of Fluosol-DA/O2 on the antitumor activity and pulmonary toxicity of bleomycin.
Teicher BA; Lazo JS; Merrill WW; Filderman AE; Rose CM
Cancer Chemother Pharmacol; 1986; 18(3):213-8. PubMed ID: 2433068
[TBL] [Abstract][Full Text] [Related]
5. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
Moulder JE; Fish BL
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
[TBL] [Abstract][Full Text] [Related]
6. Effect of a perfluorochemical emulsion on the rat hepatic mixed function oxidase system.
Ravis WR; Ramakanth S; Brzozowski DM; Hamrick ME
J Pharm Pharmacol; 1992 Mar; 44(3):219-23. PubMed ID: 1354727
[TBL] [Abstract][Full Text] [Related]
7. Plasma-mediated alterations of erythrocyte deformability by perfluorochemical blood substitutes.
Holloway GM; O'Rear EA; Fung BM
Blood; 1986 Jan; 67(1):173-6. PubMed ID: 3940545
[TBL] [Abstract][Full Text] [Related]
8. Changes of hemodynamics and O2 transport associated with the perfluorochemical blood substitute, Fluosol-DA.
Nishimura N; Sugi T
Crit Care Med; 1984 Jan; 12(1):36-8. PubMed ID: 6690204
[TBL] [Abstract][Full Text] [Related]
9. Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA.
Teicher BA; Rose CM
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1311-3. PubMed ID: 3093415
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a blood substitute (Fluosol-DA, 20%) on cerebral ischemia.
Oda Y; Handa H; Nagasawa S; Naruo Y; Asato R; Yonekawa Y
Neurol Res; 1982; 4(1-2):35-45. PubMed ID: 6127644
[TBL] [Abstract][Full Text] [Related]
11. Fluosol DA and oxygen as an adjuvant to the radiotherapeutic management of advanced head/neck carcinoma.
Lustig RA; Rose CM; McIntosh-Lowe NL
Biomater Artif Cells Artif Organs; 1988; 16(1-3):511-8. PubMed ID: 3179488
[No Abstract] [Full Text] [Related]
12. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.
Kim GE; Song CW
Cancer Chemother Pharmacol; 1989; 25(2):99-102. PubMed ID: 2513138
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases.
Mitsuno T; Ohyanagi H; Naito R
Ann Surg; 1982 Jan; 195(1):60-9. PubMed ID: 7034658
[TBL] [Abstract][Full Text] [Related]
14. The effects of fetal exchange transfusion with a red blood cell substitute.
Ambrose A; Cefalo RC; Bowes WA
Am J Obstet Gynecol; 1986 Mar; 154(3):667-74. PubMed ID: 3082209
[TBL] [Abstract][Full Text] [Related]
15. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.
Vercellotti GM; Hammerschmidt DE; Craddock PR; Jacob HS
Blood; 1982 Jun; 59(6):1299-1304. PubMed ID: 7082830
[TBL] [Abstract][Full Text] [Related]
16. The use of fluorocarbon emulsions in cancer radiotherapy.
Guichard M
Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771
[TBL] [Abstract][Full Text] [Related]
17. Effects of intravenously infused Fluosol-DA 20% in rats.
West L; McIntosh N; Gendler S; Seymour C; Wisdom C
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1319-23. PubMed ID: 3759552
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic profile of adverse clinical reactions to Fluosol-DA 20%.
Tremper KK; Vercellotti GM; Hammerschmidt DE
Crit Care Med; 1984 May; 12(5):428-31. PubMed ID: 6713912
[TBL] [Abstract][Full Text] [Related]
19. Changes in human cultured cells exposed to a perfluorocarbon emulsion.
Wake EJ; Studzinski GP; Bhandal A
Transfusion; 1985; 25(1):73-7. PubMed ID: 2982223
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with Fluosol-DA (20%) in the United States.
Tremper KK; Levine EM; Waxman K
Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
